Mechanisms of Antimicrobial Resistance Flashcards

1
Q

What are the three broad categories of anti-microbial resistance?

A

Inactivate or modify the drug (B-lactamase/penicillinase); Alter the antibacterial target (MRSA); Reduce the ability of the drug to get to the target (Block influx, increase efflux)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where are porins found and how do they mediate antibiotic susceptibility or resistance?

A

Porins are found in the outer membrane of gram negative bacteria and regulate the selective uptake of essential nutrients and other hydrophilic compounds (including some hydrophilic antibiotics). Changes in their configuration or number may adversely affect the uptake of antibiotics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where are efflux pumps found and how do they mediate antibiotic susceptibility or resistance?

A

Efflux pumps are located in the cell membranes of both gram positive and gram negative bacteria. Function and structure are very similar to P-glycoproteins and remove toxic substances from the bacterial cytoplasm. May be specific for a certain class of drugs or be more general and cause multi-drug resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the basic structure of peptidoglycan?

A

Peptidoglycan precursor subunits consist of a disaccharide backbone (GlcNAc and MurNAc) with a five peptide chain attached to the MurNAc sugar. The 2 distal amino acids are both D-alanine. The precursors are formed in the cytoplasm and then transported across the cell membrane and added to the existing structure by membrane bound penicillin binding proteins. Transglycosylases link the sugar backbone in B-1-4 linkages, and transpeptidases crosslink the peptide chains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do B-lactam antibiotics affect the formation of peptidoglycan?

A

B-lactam antibiotics bind irreversibly to the transpeptidase enzymes and inhibit peptide cross-linking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do bacteria become resistant to B-lactams?

A

1) Modifying the drug - through enzymatic destruction by B-lactamases (penicillinases). 2) Modifying the target - through production of altered penicillin binding proteins that have low affinity for B-lactam binding. 3) Preventing drug-target interaction through porin channel mutations or efflux mechanisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do narrow spectrum B-lactamases affect and what classes of bacteria have them?

A

Narrow spectrum B-lactamases hydrolyze penicillin type antibiotics (pen, ampicillin, amoxicillin) but NOT cephalosporins. They are found in both gram positive and gram negative organisms, with frequencies ranging from near 95% in S. aureus to less common in E. coli.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are three narrow B-lactamases and what species carry them?

A

“bla” gene on plasmid in Staphylococci. TEM-1 on plasmid in E. coli and H. influenzae. SHV-1 in chromosome of Klebsiella pneumoniae. All confer resistance to PCN and ampicillin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are ESBLs, what do they act on, and where are they found?

A

Extended Spectrum B-Lactamases are mutated forms of TEM-1, TEM-2, and SHV-1 that are capable of acting on cephalosporins including 3rd generation cephalosporins - ceftriaxone and ceftazidime. They are usually found on plasmids and nearly exclusively in Gram-negative rods.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are two ESBLs and what species carry them?

A

CTX-M is found in E. coli. SHV-type is found in Klebsiella pneumoniae. Both confer resistance to PCN, amp, and cephalosporins. Susceptible to some B-lactamse inhibitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the ampC B-lactamase, what does it act on, and where is it found?

A

ampC B-lactamase is capable of hydrolyzing all penicillins and 1st, 2nd, and 3rd generation cephalosporins, is not susceptible to B-lactamase inhibitors, and is found in the chromosomes of certain Gram-negative rods: Enterobacter, Pseudomonas, and a few others.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What determines whether an organism that possesses the ampC B-lactamase is susceptible to 3rd gen cephalosporins?

A

Whether or not its expression of ampC is induced or constitutive. In its normal, inducible state, the organism will be resistant to ampicillin and cefazolin (1st gen) b/c they induce its production, but susceptible to 3rd gen cephs and PIP-TAZ because they do not. If the organism mutates and ampC becomes constitutively activated, it will be resistant to all of these drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the inherent danger in treating an Enterobacter or Pseudomonas infection?

A

Treatment of a strain that houses inducible ampC with a drug such as ceftriaxone (or PIP-TAZ, or ceftazidime) may select for a constitutive mutant during therapy, resulting in a constitutive ampC, multi drug resistant infection. These must be treated with a carbapenem!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are two Carbapenemases?

A

Carbapenems are B-lactam antibiotics with the broadest spectrum of activity against Gram-negative rods and are used in cases where antibiotic resistance is a concern. Carbapenemases are plasmid mediated enzymes that cleave these and almost all other B-lactam drugs. KPC - Klebsiella Pneumoniae Carbapenemase cleaves all carbs and all B-lactams. NDM-1 - New Dehli Metalo-carbapenemase cleaves all carbs and all B-lactams except aztreonam.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What sorts of PBP alterations may there be and which organisms display what types?

A

Mutations in PBP may occur through mutation of existing genes or through acquisition of new PBP genes or gene fragments. Staphylococcus (MRSA) produces an inherited (mutation) gene, mecA, which encodes PBP2a and is resistant to all PBP except 5th gen cephs. S. pneumoniae and N. gonorrhea both may “pick up” naked DNA and insert it into their PBP genes, creating mosaic proteins with low affinity for B-lactamases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does vancomycin work?

A

Vancomycin interrupts cell wall formation by binding to the terminal D-alanine-D-alanine portion of the five member peptide chain.

17
Q

How does Enterococcus become vancomycin resistant?

A

Enterococcus has developed plasmids containing vanA or vanB which substitute D-lactate in place of the final D-alanine residue. This D-lactate has less affinity for vancomycin resulting in high level clinical resistance.

18
Q

How does Staphylococcus display reduced sensitivity to vancomycin?

A

Their cell walls contain markedly thickened layers of peptidoglycan which show less of the cross linking between peptides. They still contain the D-alanine-D-alanine terminus and the vancomycin still binds, but becomes incorporated into the cell wall and does not exert any additional effect. This happens infrequently due to the complex process necessary for the change to occur, and only occurs in patients on prolonged vancomycin therapy.

19
Q

How do bacteria become resistant to quinolones?

A

Quinolones (ciprofoxacin, levofloxacin, moxifloxacin) act by binding to DNA gyrase or topoisomerase IV and causing dsDNA breaks. Bacteria come resistant primarily through modifying the target enzymes with specific amino acid changes in the subunits of DNA gyrase and topoisomerase. These changes occur in the quinolone-resistance-determining-region on GyrA (gyrase) or ParC (topo).

20
Q

How do bacteria become resistant to macrolides?

A

Macrolides (azithromycin, clarithromycin, erythromycin) all act by binding to the 50s subunit of the bacterial ribosome and inhibiting peptide chain elongation. Bacteria commonly modify the target protein or prevent drug-target interaction via efflux pumps.

21
Q

How do bacteria modify their target proteins to resist macrolides?

A

The 23s protein of the 50s ribosomal subunit is dimethylated by the erm gene product. This methylation confers resistance to macrolides and Clindamycin (from a different antibio family). erm can be inducible or constitutive, and is induced by macrolides only. Isolates with erm will test resistant to macrolides, but sensitive to Clindamycin.

22
Q

How do bacteria reduce drug-target interactions by macrolides?

A

Efflux channels pump the drug out of the cytoplasm and causes resistance to macrolides. Isolates with efflux channels will test resistant to macrolides, but sensitive to clindamycin.

23
Q

Why was the D-test developed and how does it work?

A

Bacteria that have the phenotype Macrolide R Clindamycin S may either have efflux pumps or erm. It is fine to treat efflux pump bac with Clind, but treating erm+ bac with Clind may result in constitutive erm infections. The D-test differentiates between these two by plating the organism and then applying a macrolide disk very close to a Clindamycin disk. The erm gene will be induced by the macrolide, causing resistance to the Clind as well, resulting in a D shaped ring around the Clind disk.

24
Q

How do bacteria develop resistance to aminoglycosides?

A

Bacteria utilize all three methods to become resistant to aminoglycosides. Modify the drug - covalent bonding of the drug; Modify the target - Plasmid encoded enzyme that methylates the 16s ribosomal subunit to which aminoglycosides bind; Preventing drug-target interaction.

25
Q

How do bacteria prevent drug-target interactions of aminoglycosides?

A

The uptake of aminoglycosides is dependent on a sufficient electrochemical gradient established by the bacterial electron transport chain. Anaerobic bacteria do not possess electron transport chains, and thus do not have an electrochemical gradient to bring aminoglycosides into their cells. Thus, in general, anaerobic bacteria are resistant to aminoglycosides.

26
Q

Who do bacteria modify aminoglycosides to gain resistance?

A

More than 30 aminoglycoside-modifying enzymes have been identified. They are capable of three general reactions: N-acetylation, O-nucleotidylation, O-phosphorylation. Modification of aminoglycosides by these mechanisms leads to high level resistance.